ICON has acquired Symphony Clinical Research, a provider of at-home patient and site support services.
Symphony’s services reduce the travel burden for patients which broadens ICON’s recruitable population, providing patients access to clinical research studies that they may not have otherwise been able to participate in.
Headquartered in Vernon Hills, Illinois, U.S. and Gdansk, Poland, Symphony Clinical Research has been operating since 2003 and has serviced global trials in over 50 countries for biopharma companies across many major therapeutic areas, including cardiovascular, immunology, oncology and respiratory.
“As the pioneer in alternate-site services, Symphony integrates clinical trial expertise with project management; in-home care and nursing to bring the site visit to the patient wherever they live. ICON provides Symphony with a great opportunity to extend our services globally and to use our knowledge, infrastructures and network to support ICON to enhance patient recruitment, engagement and retention.” Nicki Norris, Chief Executive Officer, Symphony Clinical Research, said.
“ICON has a focused patient, site and data strategy which is helping us to improve site identification, study placement, patient recruitment and retention,” Dr. Steve Cutler, Chief Executive Officer, ICON said. “A core objective of our patient centered approach is to increase predictability in patient recruitment and improve patient engagement. Symphony Clinical Research further enhances this approach by providing us with the capability to offer patients at-home trial services making clinical trials more accessible for patients and improving enrollment. Symphony’s clinical trial experience and their strong therapeutic expertise will also enable us to broaden our hybrid trial solutions to customers and support services to sites.”